uniQure (QURE) Return on Capital Employed (2017 - 2026)
uniQure (QURE) posted quarterly Return on Capital Employed of 25.05% for Q2 2026, up 548.0% year-over-year from 3.87% in Q2 2025, and up 2.96% quarter-over-quarter from 25.82% in Q1 2026.
uniQure (QURE) Return on Capital Employed (2017 - 2026) Analysis & Trends
uniQure's Return on Capital Employed history runs 10 years deep, the most recent figure standing at 25.05% for Q2 2026.
- In Q2 2026, Return on Capital Employed rose 548.0% year-over-year to 25.05%; the TTM figure through Jun 2026 stood at 25.05% (up 548.0% YoY), while the FY2025 annual figure was 29.52%, down 135.0% from the prior year.
- Return on Capital Employed for Q2 2026 stood at 25.05%, up from 25.82% in the prior quarter.
- The five-year high for Return on Capital Employed was 40.76% in Q1 2022, with the low at 36.36% in Q4 2023.
- The 5-year median for Return on Capital Employed is 27.4% (2022), against an average of 24.74%.
- Peak annual rise in Return on Capital Employed reached 8308 bps in 2022, while the deepest fall reached 7945 bps in 2022.
- uniQure's Return on Capital Employed stood at 24.03% in 2022, then slumped by 51 bps to 36.36% in 2023, then rose by 10 bps to 32.84% in 2024, then climbed by 29 bps to 23.35% in 2025, then slipped by 7 bps to 25.05% in 2026.
- Business Quant data shows QURE's Return on Capital Employed at 25.05% in Q2 2026, 25.82% in Q1 2026, and 23.35% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.76% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.74% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -55.45% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.20% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 7.88% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 26.09% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -50.93% |
| 10 | uniQure | 3.37 Bn | 3.37 Bn | 5.49 Mn | -25.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.05% |
| Mar 31, 2026 | -25.82% |
| Dec 31, 2025 | -23.35% |
| Sep 30, 2025 | -28.31% |
| Jun 30, 2025 | -30.54% |
| Mar 31, 2025 | -31.10% |
| Dec 31, 2024 | -32.84% |
| Sep 30, 2024 | -32.45% |
| Jun 30, 2024 | -36.10% |
| Mar 31, 2024 | -35.66% |
| Dec 31, 2023 | -36.36% |
| Sep 30, 2023 | -23.21% |
| Jun 30, 2023 | -23.97% |
| Mar 31, 2023 | -27.13% |
| Dec 31, 2022 | -24.03% |
| Sep 30, 2022 | -27.67% |
| Jun 30, 2022 | -22.48% |
| Mar 31, 2022 | 40.76% |
| Dec 31, 2021 | 41.13% |
| Sep 30, 2021 | 40.72% |